1 in 2 people will faint at some time in their life - ALLIANCE WORLD HEART RHYTHM WEEK 4 - 10 JUNE 2018
4 June 2018, Oxfordshire STARS (Syncope Trust And Reflex anoxic Seizures) is celebrating its 25th anniversary and will be raising awareness of the link between fainting and arrhythmias (heart rhythm disorders) during the Arrhythmia Alliance World Heart Rhythm Week.
ARRHYTHMIA ALLIANCE WORLD HEART RHYTHM WEEK 4 - 10 JUNE 2018 - STARS
6.1 million Americans at risk of deadly stroke due to an irregular heart rhythm known as atrial fibrillation
Free Pulse Checks for Londoners during Global AF Awareness Week
More than 150,0000 Londoners have the most common type of irregular heartbeat, which is called Atrial Fibrillation or AF, and are at higher risk of a stroke. Not everyone with AF has symptoms and a simple pulse rhythm check could save their life.
INTERNATIONAL HEART RHYTHM CONGRESS CALLS FOR URGENT ACTION TO PREVENT THOUSANDS OF UNNECESSARY DEATHS FROM ARRHYTHMIAS..
Over 3,000 heart rhythm specialists and healthcare professionals from around the world are arriving in Birmingham for the annual Heart Rhythm Congress (HRC), starting on Sunday (1-4 October), the UK’s largest educational congress devoted solely to arrhythmias (heart rhythm disorders).
ARRHYTHMIA ALLIANCE WELCOMES NHS CALL TO PROVIDE TESTS TO IDENTIFY PEOPLE WITH UNDIAGNOSED HEART RHYTHM DISORDERS
Local health authorities do not mandate or commission manual pulse rhythm checks recommended as part of NHS health check service
Interview with Trudie Lobban MBE, Founder & Trustee of Arrhythmia Alliance
Arrhythmia Alliance is a coalition of charities, patient groups, patients, carers, healthcare professionals, policy-makers, politicians, allied professionals and all those involved in the care of or affected by cardiac arrhythmias. Arrhythmia Alliance works in collaboration to improve diagnosis, treatment and quality of life for all those suffering with arrhythmias.
Screening for atrial fibrillation: a European Heart Rhythm Association (EHRA) consensus document endorsed by the Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS), and Sociedad Latinoamericana de Estimulación Cardíaca y Electrofisiología (SOLAECE)
Atrial fibrillation (AF) is the most common cardiac arrhythmia, occurring in 1–2% of the general population. Its prevalence varies between continents and ethnicity, but the estimated number of patients with AF worldwide might be between 30 and 100 million.1 This prevalence is expected to increase significantly in the next 30–50 years due to an ageing population, and increasing risk factors to develop AF, including arterial hypertension and diabetes.2–5 In all populations studied, both prevalence and incidence are higher in men than in women and increase with age.6